Engineers Gate Manager’s ImmunityBio IBRX Stock Holding History

Engineers Gate Manager’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$854K	Buy	97,576 +83,173	+577%	+$630K	0.01%	1183
2026 Q1	$110K	Sell	14,403 -12,565	-47%	-$86K	﹤0.01%	2006
2025 Q4	$53.4K	Buy	26,968 +3,578	+15%	+$8.11K	﹤0.01%	1972
2025 Q3	$57.5K	Buy	23,390 +10,160	+77%	+$26.2K	﹤0.01%	2050
2025 Q2	$34.9K	Buy	+13,230	New	+$35.6K	﹤0.01%	2074
2025 Q1	–	Sell	-92,377	Closed	-$236K	–	2345
2024 Q4	$236K	Buy	+92,377	New	+$385K	﹤0.01%	1825
2023 Q4	–	Sell	-13,632	Closed	-$23K	–	2078
2023 Q3	$23K	Buy	+13,632	New	+$27.4K	﹤0.01%	1702
2022 Q2	–	Sell	-20,292	Closed	-$114K	–	2057
2022 Q1	$114K	Sell	20,292 -16,673	-45%	-$102K	﹤0.01%	1692
2021 Q4	$225K	Buy	+36,965	New	+$278K	0.01%	1577
2021 Q3	–	Sell	-87,745	Closed	-$1.25M	–	1790
2021 Q2	$1.25M	Buy	87,745 +55,913	+176%	+$924K	0.08%	339
2021 Q1	$756K	Buy	+31,832	New	+$825K	0.04%	728

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Engineers Gate Manager's IBRX Position: Q2 2026 in Review

Engineers Gate Manager increased its ImmunityBio (IBRX) stake by 577% in Q2 2026, buying an estimated $630K and bringing the position to 97,576 shares worth $854K. The position accounts for 0.01% of the portfolio, ranked #1183.

Engineers Gate Manager first reported a position in IBRX in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.25M in Q2 2021. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Engineers Gate Manager held 97,576 shares of ImmunityBio worth $854K as of Q2 2026.
Engineers Gate Manager bought 83,173 ImmunityBio shares in Q2 2026, an estimated $630K.
ImmunityBio made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1183 holding.
Engineers Gate Manager first reported a position in ImmunityBio in Q1 2021 and has held it in 11 quarters since.
Engineers Gate Manager's ImmunityBio position peaked at $1.25M in Q2 2021.
404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.